{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:23:19Z","timestamp":1770639799780,"version":"3.49.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.hoc.2008.07.004","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T09:21:01Z","timestamp":1225185661000},"page":"807-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Molecular Biology and Genetics of Lymphomas"],"prefix":"10.1016","volume":"22","author":[{"given":"Elena M.","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2008.07.004_bib1","series-title":"World Health Organization classification of tumors. Pathology and genetics of tumours of haematopoetic and lymphoid tissues","year":"2001"},{"issue":"26","key":"10.1016\/j.hoc.2008.07.004_bib2","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1200\/JCO.2005.05.012","article-title":"Molecular pathogenesis of diffuse large B-cell lymphoma","volume":"23","author":"Lossos","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7017","key":"10.1016\/j.hoc.2008.07.004_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.hoc.2008.07.004_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","article-title":"Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program","volume":"17","author":"Shaffer","year":"2002","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.hoc.2008.07.004_bib6","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.hoc.2008.07.004_bib7","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/sj.onc.1210901","article-title":"Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma","volume":"27","author":"Stocklein","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.hoc.2008.07.004_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/leu.2008.18","article-title":"DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status","volume":"22","author":"Pike","year":"2008","journal-title":"Leukemia"},{"issue":"6844","key":"10.1016\/j.hoc.2008.07.004_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.hoc.2008.07.004_bib10","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"10.1016\/j.hoc.2008.07.004_bib11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"6769","key":"10.1016\/j.hoc.2008.07.004_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.hoc.2008.07.004_bib13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.hoc.2008.07.004_bib14","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood.V95.5.1797.005k30_1797_1803","article-title":"Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas","volume":"95","author":"Lossos","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2008.07.004_bib15","first-page":"348","article-title":"Gene expression signatures predict overall survival in diffuse large B cell lymphoma treated with rituximab and CHOP-like chemotherapy","volume":"110","author":"Lenz","year":"2007","journal-title":"ASH Annual Meeting Abstracts"},{"issue":"11","key":"10.1016\/j.hoc.2008.07.004_bib16","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","volume":"103","author":"Rimsza","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.hoc.2008.07.004_bib18","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2008.07.004_bib19","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2005-02-0542","article-title":"Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma","volume":"106","author":"Tagawa","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2008.07.004_bib20","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood-2005-07-2950","article-title":"Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas","volume":"107","author":"Chen","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2008.07.004_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20052204","article-title":"Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma","volume":"203","author":"Pasqualucci","year":"2006","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.hoc.2008.07.004_bib22","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a\u00a0tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2008.07.004_bib23","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","article-title":"Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications","volume":"109","author":"Jost","year":"2007","journal-title":"Blood"},{"issue":"7089","key":"10.1016\/j.hoc.2008.07.004_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":"A loss-of-function RNA interference screen for molecular targets in cancer","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"issue":"5870","key":"10.1016\/j.hoc.2008.07.004_bib25","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.hoc.2008.07.004_bib27","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2008.07.004_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.004_bib29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.hoc.2008.07.004_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","article-title":"Bim: a novel member of the Bcl-2 family that promotes apoptosis","volume":"17","author":"O'Connor","year":"1998","journal-title":"Embo J"},{"issue":"5","key":"10.1016\/j.hoc.2008.07.004_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","article-title":"Role of genetic and epigenetic changes in Burkitt lymphoma","volume":"12","author":"Lindstrom","year":"2002","journal-title":"Semin Cancer Biol"},{"issue":"7052","key":"10.1016\/j.hoc.2008.07.004_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants","volume":"436","author":"Hemann","year":"2005","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.hoc.2008.07.004_bib33","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.hoc.2008.07.004_bib34","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/sj.leu.2403080","article-title":"Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study","volume":"17","author":"Garcia","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"issue":"23","key":"10.1016\/j.hoc.2008.07.004_bib36","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.hoc.2008.07.004_bib37","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 1)","key":"10.1016\/j.hoc.2008.07.004_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/11.suppl_1.S23","article-title":"Follicular lymphoma: have we made any progress?","volume":"11","author":"Horning","year":"2000","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2008.07.004_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc2297","article-title":"Diagnosing and exploiting cancer's addiction to blocks in apoptosis","volume":"8","author":"Letai","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"6306","key":"10.1016\/j.hoc.2008.07.004_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"BCL-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.hoc.2008.07.004_bib42","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1073\/pnas.91.19.8910","article-title":"BCL2 translocation frequency rises with age in humans","volume":"91","author":"Liu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.hoc.2008.07.004_bib43","first-page":"2271","article-title":"Bcl-2\/JH rearrangements in benign lymphoid tissues with follicular hyperplasia","volume":"6","author":"Limpens","year":"1991","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.hoc.2008.07.004_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.1103","article-title":"Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)","volume":"30","author":"Horsman","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2008.07.004_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1044-579X(03)00014-2","article-title":"Cytogenetic evolution of follicular lymphoma","volume":"13","author":"Viardot","year":"2003","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.hoc.2008.07.004_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.10314","article-title":"Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas","volume":"39","author":"Hoglund","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"23","key":"10.1016\/j.hoc.2008.07.004_bib47","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1200\/JCO.2002.12.006","article-title":"Clinicopathologic correlations of genomic gains and losses in follicular lymphoma","volume":"20","author":"Viardot","year":"2002","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.hoc.2008.07.004_bib48","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1200\/JCO.2005.26.856","article-title":"Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors","volume":"23","author":"de Jong","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2008.07.004_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2008.07.004_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1044-579X(03)00015-4","article-title":"Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions","volume":"13","author":"Lossos","year":"2003","journal-title":"Semin Cancer Biol"},{"issue":"21","key":"10.1016\/j.hoc.2008.07.004_bib51","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2008.07.004_bib52","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.hoc.2008.07.004_bib53","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2008.07.004_bib54","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2008.07.004_bib55","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1182\/blood-2007-10-115915","article-title":"Clinical quantitation of immune signature in follicular lymphoma by RT-PCR based gene expression profiling","volume":"111","author":"Byers","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2004-06-2298","article-title":"Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment","volume":"105","author":"Glas","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2008.07.004_bib57","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"issue":"14","key":"10.1016\/j.hoc.2008.07.004_bib58","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0959-8049(99)00292-0","article-title":"Control of the cell cycle and apoptosis","volume":"35","author":"Lundberg","year":"1999","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2008.07.004_bib59","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2002-01-0263","article-title":"Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis","volume":"101","author":"Quintanilla-Martinez","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2008.07.004_bib60","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1101\/gad.11.11.1464","article-title":"Cyclin E-CDK2 is a regulator of p27Kip1","volume":"11","author":"Sheaff","year":"1997","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.hoc.2008.07.004_bib61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood"},{"issue":"32","key":"10.1016\/j.hoc.2008.07.004_bib62","doi-asserted-by":"crossref","first-page":"30339","DOI":"10.1074\/jbc.M303969200","article-title":"Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation","volume":"278","author":"Solomon","year":"2003","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.hoc.2008.07.004_bib63","first-page":"7056","article-title":"An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene","volume":"63","author":"Lu","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.hoc.2008.07.004_bib64","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1182\/blood-2006-04-016634","article-title":"Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity","volume":"108","author":"Marzec","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.004_bib65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2407-6-238","article-title":"Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma","volume":"6","author":"Krieger","year":"2006","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2008.07.004_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.hoc.2008.07.004_bib67","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions\u00a0in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2008.07.004_bib68","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"Embo J"},{"issue":"15","key":"10.1016\/j.hoc.2008.07.004_bib69","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovec","year":"1994","journal-title":"Embo J"},{"issue":"12","key":"10.1016\/j.hoc.2008.07.004_bib70","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2008.07.004_bib71","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature","volume":"25","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2008.07.004_bib72","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2004-10-3907","article-title":"Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome","volume":"105","author":"Rubio-Moscardo","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2008.07.004_bib73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2003-12-4175","article-title":"Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions","volume":"104","author":"Kohlhammer","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2008.07.004_bib74","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"10.1016\/j.hoc.2008.07.004_bib75","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","article-title":"Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways","volume":"23","author":"Fernandez","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2008.07.004_bib76","first-page":"2409","article-title":"BMI-1 gene amplification and over-expression in hematological malignancies occur mainly in mantle cell lymphomas","volume":"61","author":"Bea","year":"2001","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.hoc.2008.07.004_bib77","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-04-1526","article-title":"CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a\/ARF locus","volume":"65","author":"Hernandez","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib78","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas","volume":"89","author":"Pinyol","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2008.07.004_bib79","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1182\/blood-2006-11-057208","article-title":"Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis","volume":"109","author":"Pinyol","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2008.07.004_bib80","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","article-title":"Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones","volume":"89","author":"Ott","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2008.07.004_bib81","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.050400997","article-title":"Mantle cell lymphoma is characterized by inactivation of the ATM gene","volume":"97","author":"Schaffner","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib82","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.leu.2403571","article-title":"Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms","volume":"19","author":"Tort","year":"2005","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.hoc.2008.07.004_bib83","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1182\/blood-2002-04-1078","article-title":"CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas","volume":"100","author":"Tort","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2008.07.004_bib84","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.10891","article-title":"Increased MDM2 expression is associated with inferior survival in mantle-cell lymphoma, but not related to the MDM2 SNP309","volume":"92","author":"Hartmann","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2008.07.004_bib85","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2008.07.004_bib86","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2008.07.004_bib87","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood.V86.8.2892.2892","article-title":"p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)","volume":"86","author":"Louie","year":"1995","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.hoc.2008.07.004_bib88","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/hmg\/ddh195","article-title":"Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes","volume":"13","author":"de Leeuw","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.hoc.2008.07.004_bib89","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM","volume":"24","author":"Tagawa","year":"2005","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.hoc.2008.07.004_bib90","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858808001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858808001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:53:15Z","timestamp":1760183595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858808001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0889858808001044"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2008.07.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Biology and Genetics of Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2008.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}